2011
DOI: 10.1111/j.1365-2249.2011.04476.x
|View full text |Cite
|
Sign up to set email alerts
|

Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2012
2012
2014
2014

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 34 publications
(37 reference statements)
1
7
0
Order By: Relevance
“…Correia et al and Darras et al also reported on remission of severe solar urticaria in single patients following high dose IVIG infusion [51,52]. While the poor response seen in the one report by Llamas-Velasco et al, may have been due to differences in product or dosage protocol, it is also quite possible that solar urticaria is a heterogeneous disease, with Alters cellular recruitment [37,43] Limits complement activation and dampens complement-mediated vascular and tissue injury [37] Inhibits inflammatory cytokines and induces inhibitory cytokines By altering Th1/2 or Th17 maturation as well as modulating glucocorticoid receptors or Fcgamma receptors on T cells and inflammatory cells [34,42,44,45] or by inhibiting T cell activation [5,37] Decreased adhesion to endothelial cells [43] Adaptive Immunity…”
Section: Efficacy Of Ivig In Urticarial Syndromesmentioning
confidence: 95%
See 3 more Smart Citations
“…Correia et al and Darras et al also reported on remission of severe solar urticaria in single patients following high dose IVIG infusion [51,52]. While the poor response seen in the one report by Llamas-Velasco et al, may have been due to differences in product or dosage protocol, it is also quite possible that solar urticaria is a heterogeneous disease, with Alters cellular recruitment [37,43] Limits complement activation and dampens complement-mediated vascular and tissue injury [37] Inhibits inflammatory cytokines and induces inhibitory cytokines By altering Th1/2 or Th17 maturation as well as modulating glucocorticoid receptors or Fcgamma receptors on T cells and inflammatory cells [34,42,44,45] or by inhibiting T cell activation [5,37] Decreased adhesion to endothelial cells [43] Adaptive Immunity…”
Section: Efficacy Of Ivig In Urticarial Syndromesmentioning
confidence: 95%
“…Antigen presentation is affected by decreased expression of costimulatory molecules such as CD40, CD80/86 or HLA molecules. T regulatory cells may be induced by IVIG by upregulation of CD25+/CD4+/FOXP3+ or via complex cytokine pathways [5,37,42,44,45]. Anthony et al have recently reported that some of the observed anti-inflammatory effects of IVIG are mediated by a minor population of IgG crystallizable fragments that possess glycans and sialic acids that bind to DC-SIGN (dendritic cell specific ICAM-3 grabbing non-integrin) [42].…”
Section: Effects Of Ivig On Adaptive Immunitymentioning
confidence: 96%
See 2 more Smart Citations
“…It may skew peripheral blood T cell subsets in multiple beneficial ways, including suppression of pro-inflammatory Th17 cells [25][26][27], promotion of protective CD4/CD25/FoxP3-positive T regulatory cells [28][29][30][31][32], induction of a protective Th1/Th2 shift [33][34][35], and inhibition of CD8-positive cytotoxic T cell activation and expansion [36,37]. Importantly, polyclonal IgG may inhibit T cell interactions with antigen-presenting cells by binding to T cell surface receptors, including the T cell receptor b-chain, HLA molecules, and costimulatory molecules such as CD28 [38][39][40][41]. In addition, it was demonstrated that polyclonal IgG inhibits the in vitro proliferation of human T cell lines reactive against myelin basic protein (MBP) [42].…”
Section: Reviewmentioning
confidence: 99%